Booster doses for inactivated COVID-19 vaccines: if, when, and for whom.

Croda, Julio; Ranzani, Otavio T

Croda, Julio; Ranzani, Otavio T.

Croda J; Universidade Federal de Mato Grosso do Sul, Campo Grande, 79081-746, Brazil; Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, Brazil; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA. Electronic address: julio.croda@fiocruz.br.
Ranzani OT; Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain; Pulmonary Division, Heart Institute (InCor), HCFMUSP, Faculdade de Medicina da Universidade de São Paulo, Brazil.

Lancet Infect Dis ; 22(4): 430-432, 2022 04.

Article in English | MEDLINE | ID: covidwho-1565674

Subject(s)

COVID-19; Haemophilus Vaccines; Antibodies, Viral; COVID-19/prevention & control; COVID-19 Vaccines; Humans; Immunization, Secondary; Poliovirus Vaccine, Inactivated; Vaccines, Inactivated

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Haemophilus Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google